SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

Cantor Fitzgerald Maintains Overweight on TG Therapeutics, Lowers Price Target to $19

Cantor Fitzgerald maintains TG Therapeutics (NASDAQ:TGTX) with a Overweight and lowers the price target from $20 to $19.

Benzinga · -

Cantor Fitzgerald maintains TG Therapeutics (NASDAQ:TGTX) with a Overweight and lowers the price target from $20 to $19.